A signal change for antifungal agents

September 13, 2010
In vivo imaging reveals the binding sites of theonellamide (TNM), a novel antifungal agent. The upper panels show a differential interference contrast micrograph of a yeast cell (left) and a fluorescent image of the cell stained with the membrane probe filipin (right), where the brightness indicates filipin binding at the cell membrane. The lower panels show a fluorescent image of a cell stained with TNM (left) and a merged image (right) of the cell labeled with TNM (red) and stained with filipin (green). Copyright : Reproduced, in part, from Ref. 1 © 2010 Shinichi Nishimura et al.

Chemical-genomic profiling of bioactive therapeutic compounds reveals therapeutically exploitable signaling activity at fungal cell membranes.

While some fungal species, such as shiitake and enoki, are edible, some microscopic species can trigger numerous infections in the human body. Antifungal drugs are the best means to fight these parasitic species; however, because mammalian and share many similarities, such as lipid-based membranes, these medications can produce serious side-effects.

Now, researchers led by Minoru Yoshida from the RIKEN Advanced Science Institute in Wako, have characterized the biological properties of theonellamide (TNM), an antifungal natural product isolated from marine sponges1. They found that, unlike typical modes of action, TNM specifically targets ergosterol lipid molecules in fungal cell membranes, not proteins. This bonding interaction rapidly activates a called Rho1 to over-produce 1,3-β-D-glucan sugar chain molecules—a process that forms an aberrant fungal cell wall. This unique mechanism promises to spur development of innovative antifungal agents. “We believe that TNM is the first compound that activates membrane signaling molecules by binding to a lipid,” says Yoshida.

Despite previous efforts to identify TNM’s specific biological actions, its sub-cellular targets were unknown until now. Yoshida and colleagues used a yeast complex to generate nearly 5,000 ‘open reading frames’ (ORFs), which are long strands of DNA that can encode proteins. This was to screen for sequences with altered susceptibility to TNM—so-called ‘hit genes’. Extensive bioinformatic analysis of the chemical-genomic profiles showed that the hit genes showed traits related to sterol binding, Rho-type protein activation or inhibition, and 1,3-β-D-glucan synthesis. However, none of the hit genes showed any physical interaction with TNM, demonstrating that proteins were not the primary target of this molecule.

By synthesizing fluorescently labeled TNM derivatives and comparing their in vivo localization to filipin molecules—known membrane-binding compounds—the team discovered that TNM directly targets ergosterol and related sterols in fungal cell membranes (Fig. 1). Attachment of TNM to these lipid molecules enhanced 1,3-β-D-glucan synthesis—but only in the presence of Rho1, confirming the unprecedented signaling behavior. Further experiments on Rho1 mutants determined that TNM can independently lower membrane integrity, gradually inducing lesions into the cellular structure.

The researchers’ next task—unraveling the complex mechanisms of TNM-induced membrane signaling—may throw light on how to avoid unwanted side-effects in humans during antifungal treatments. “TNM binds to not only ergosterol but also cholesterol, a mammalian counterpart,” explains Yoshida. “Our preliminary findings show that mammalian cells rapidly and transiently change morphology upon TNM treatment—making this compound a fabulous tool to dissect the function of membrane sterols in general.”

Explore further: Macromolecules on surface control mobility in phospholipid bilayers

More information: 1.Nishimura, S., Arita, Y., Honda, M., Iwamoto, K., Matsuyama, A., Shirai, A., Kawasaki, H., Kakeya, H., Kobayashi, T., Matsunaga, S. & Yoshida, M. Marine antifungal theonellamides target 3β-hydroxysterol to activate Rho1 signalling. Nature Chemical Biology 6, 519-526 (2010).

Related Stories

Nanomaterials to Mimic Cells

August 23, 2005

Mimicking a real living cell by combining artificial membranes and nanomaterials in one construction is the aim of a new research grant at UC Davis. The Nanoscale Integrated Research Team grant, funded by the National Science ...

Instruction Manual for Creating a Molecular Nose

February 12, 2007

An artificial nose could be a real benefit at times: this kind of biosensor could sniff out poisons, explosives or drugs, for instance. Researchers at the Max Planck Institute for Polymer Research and the Max Planck Institute ...

Chemists get grip on slippery lipids

August 30, 2007

The ability of the body's cells to correctly receive and convey signals is crucial to good health. Lipids, or fats, play a critical role in this regulation by providing spaces for proteins to gather and network. They are ...

Allergic response tied to lipid molecules in cell membrane

March 7, 2008

A team of Penn State University researchers is the first to demonstrate that lipid molecules in cell membranes participate in mammals' reactions to allergens in a living cell. The finding will help scientists better understand ...

Recommended for you

Brazilian wasp venom kills cancer cells by opening them up

September 1, 2015

The social wasp Polybia paulista protects itself against predators by producing venom known to contain a powerful cancer-fighting ingredient. A Biophysical Journal study published September 1 reveals exactly how the venom's ...

Naturally-occurring protein enables slower-melting ice cream

August 31, 2015

(Phys.org)—Scientists have developed a slower-melting ice cream—consider the advantages the next time a hot summer day turns your child's cone with its dream-like mound of orange, vanilla and lemon swirls with chocolate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.